HCW Biologics Inc（HCWB）美股招股说明书 S-1（2026-06-18修订版）（英文版）（8页）.pdf

1、S-1/A 1 forms-1a.htm S-1/A As filed with the Securities and Exchange Commission on June 18,2026 Registration No.333-296577 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 Amendment No.1toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 HCW BIOLOGICS INC.(Exact name o

2、f Registrant as specified in its charter)Delaware 2834 82-5024477(State or Other Jurisdiction of Primary Standard Industrial(I.R.S.EmployerIncorporation or Organization)Classification Code Number Identification Number)2929 N Commerce ParkwayMiramar,FL 33025(954)842-2024Address,including zip code,and

3、 telephone number,including area code,of Registrants principal executive offices Hing C.Wong,Ph.D.Chief Executive OfficerHCW Biologics Inc.2929 N Commerce ParkwayMiramar,FL 33025(954)842-2024Name,Address Including Zip Code,and Telephone Number,Including Area Code,of Agent for Service With a copy to:

4、James GrothClark Hill PLC130 E.Randolph St.,Ste.3900Chicago,IL 60601(312)985-5900 Yevgeniya(Jeny)ZarmonClark Hill PLC210 Carnegie Center,Suite 102Princeton,NJ 08540(609)785-2918 Approximate Date of Commencement of Proposed Sale to the Public:From time to time after the effective date of thisregistra

5、tion statement,as determined by market conditions.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offe

6、ring pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securiti